Coronavirus: The Latest

Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.Read more on the Oxford vaccine: https://bit.ly/2UVfPet |Read more on Brexit talks: https://bit.ly/36V8f8Y |Read more on the new quarantine-free list: https://bit.ly/3lMs88H |For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |Email: coronaviruspodcast@telegraph.co.uk |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After the US recorded its highest daily rise in new cases and hospitalisations, Deputy Editor of The Telegraph’s Global Health Security Team, Anne Gulland joins Theodora Louloudis to discuss the five mammoth challenges the President Elect will be seeking to overcome in his fight against Covid-19. Top of the list? Tackling misinformation.Track cases in your area: https://bit.ly/2Yohewr |Read more about the MS drug trial: https://bit.ly/3kB3nuM |For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |Email: coronaviruspodcast@telegraph.co.uk |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

After the Pfizer vaccine breakthrough, immunologist Dr Al Edwards tells Theodora Louloudis why the hard work isn't over even once a vaccine is approved, why talk of effective immunisation before Christmas is premature and how this particular vaccine could be particularly difficult to distribute.Read more about the rise in deaths in England and Wales: https://bit.ly/2GLAwWw |Read more about unemployment rates: https://bit.ly/3llycof |Read more about Welsh exams: https://bit.ly/36oNeDo |Read Sarah Newey 'We should be concerned about the 'mink virus', but not for the reasons you think': https://bit.ly/3lu966w |For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |Email: coronaviruspodcast@telegraph.co.uk |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

As Liverpool becomes England’s first city to be offered mass coronavirus testing, The Telegraph’s Health Editor Laura Donnelly tells Theodora Louloudis why the trial could offer a glimpse into the UK’s future, and why its success hinges on public co-operation.Read more the UK's R-rate: https://bit.ly/35YCHyB |Read more about Paris' coronavirus infection rates: https://bit.ly/2HXCEe4 |Read Ambrose Evans-Pritchard' 'Boris has my full support on lockdown 2.0 - even though I think he’s wrong': https://bit.ly/34T24Tl |For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |Email: coronaviruspodcast@telegraph.co.uk |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

With just eight weeks to go until the big day, Yolanthe Fawehinmi joins Theodora Louloudis to discuss the likelihood of households being allowed to mix nationwide over the festive season. Read more about England's coronavirus infection rates: https://bit.ly/31TdwMJ|Read more about the leaked sage documents: https://bit.ly/34GV4ZE|For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |Email: coronaviruspodcast@telegraph.co.uk |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Millions more Britons will soon be living under tighter coronavirus restrictions, but Sadiq Khan and Sir Keir Starmer are among the Labour MPs calling for even harsher measures. They want to see a two-week national ’circuit breaker’ lockdown, but would this diminish the problem, or simply delay it? The Telegraph’s Global Health Security Correspondent Sarah Newey tells Theodora Louloudis why the move isn't a silver bullet.Read Sarah's report from Manaus: www.bit.ly/3diYUe9 |Read more about Wales' crackdown on English visitors: https://bit.ly/3nT22lN |Read more about Germany's rise in cases: https://bit.ly/3nUEqNx |For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |Email: coronaviruspodcast@telegraph.co.uk |See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.